Transforming the Diagnosis and Management of Severe Neurocognitive Disorders through Genomics [ 2016 - 2021 ]

Research Grant

Researchers: A/Pr Tony Roscioli (Principal investigator) ,  A/Pr Gareth Baynam ,  A/Pr Marcel Dinger ,  Dr Michael Buckley ,  Dr Michael Field
View all 10 related researchers

Brief description Neurocognitive disorders (NCD) are one of the most common genetic conditions in our society and it results with a need for ongoing permanent care for many affected people. Until recently, only 30% of people with NCD could be diagnosed but this has changed with the availability of genomic testing where all genes can be tested at once. The use of genomics in the CRE will lead to new NCD genes being identified and this information being translated into a clinical setting.

Funding Amount $AUD 2,558,285.01

Funding Scheme Centres of Research Excellence

Notes Centre of Research Excellence - Clinical